Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Five Prime Thera (NQ: FPRX )

22.23 USD -0.85 (-3.68%)
Official Closing Price Updated: 5:11 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 690,100
Open 23.40
Bid (Size) 21.00 (1)
Ask (Size) 26.00 (11)
Prev. Close 23.08
Today's Range 21.88 - 23.50
52wk Range 1.750 - 26.25
Shares Outstanding 35,209,289
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference 
From Business Wire News Releases
Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference 
From Business Wire News Releases

Performance

YTD
+27.39%
+27.39%
1 Month
+40.08%
+40.08%
3 Month
+18.24%
+18.24%
6 Month
+420.61%
+420.61%
1 Year
+480.42%
+480.42%

More News

Read More
Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day
From Business Wire News Releases
Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab Plus Chemotherapy as a Frontline Targeted Treatment for FGFR2b+ G
From Business Wire News Releases
Five Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab at American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Virtual Annual Symposium
From Business Wire News Releases
We Did The Math PBE Can Go To $82
Tags ETFs
From ETF Channel
Five Prime Announces Closing of Upsized Public Offering of Common Stock
From Business Wire News Releases
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics?
From PR Newswire
First Week of January 15th Options Trading For Five Prime Therapeutics (FPRX)
Tags Stocks
From Market News Video
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
Tags JAGX VIRI AVEO
From Benzinga
Thinking about buying stock in Zomedica, Zosano Pharma, TapImmune, Five Prime Therapeutics, or Inuvo?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.